Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from participants who have received capsules from a more recently ma ...

Catherine Laborde, who presented weather on TF1 in France for nearly 30 years, has died. Laborde passed away on Tuesday, Jan. 28 following a years-long battle with Lewy Body Dementia (LBD), which she ...

Cognition Therapeutics, Inc. announced promising results from the SHIMMER study of zervimesine (CT1812) in patients with mild-to-moderate dementia with Lewy bodies (DLB), to be presented by Dr ...

One of the most common early signs of dementia is short-term memory loss—as is forgetting important dates or events, ...

CervoMed (CRVO) provided an update on its neflamapimod development program in dementia with Lewy bodies, DLB, as part of an oral presentation ...

Cognition Therapeutics (CGTX) announced that JamesGalvin, MD, MPH will present topline results from the ‘SHIMMER’ study of zervimesine in ...

Among patients with iRBD, altered visuospatial cue-elicited N2 and P3 ERPs predicted phenoconversion to α-synucleinopathies.

Two Fountain Hills women are working to make their town "dementia friendly" so that other caretakers know that they are not ...

dementia with Lewy body, and frontotemporal dementia. The key points of clinical differences of these dementia syndromes are summarized in this article. Prevalence of dementia is increasing due to ...

A once-a-day pill that could be the “holy grail” in the treatment of Alzheimer’s disease is a step closer to becoming a ...

Many people use the terms Alzheimer’s disease and dementia as if they mean the same thing, but they actually refer to ...